Quantitative Biology > Molecular Networks
[Submitted on 3 Jun 2010 (this version), latest version 21 Dec 2010 (v2)]
Title:Biological control networks suggest the use of biomimetic sets for combinatorial therapies
View PDFAbstract:Nature uses combinatorial control strategies that are different from those used by present pharmacological approaches for controlling disease. Function and differentiation of cells and organisms are naturally regulated by control networks that are bipartite, i.e. contain two different types of nodes: controllers and targets. Each controller acts on many targets, and target nodes are controlled by many controllers in a strongly overlapping many-to-many network structure. We present a quantitative analysis of the network properties of three key biological systems for which sufficiently comprehensive datasets are now available: transcription factors, microRNAs and protein kinases. We find that some parameters defining general network properties vary only within limited ranges, suggesting the existence of common control strategies in biology. The many-to-many structure might permit higher robustness to variation. A mathematical model also provides insight into the factors determining the values of the biological control network parameters and the network structure. The model showed an increased probability of finding solutions that achieve control within the naturally occurring range. This analysis of biological control networks suggests a new paradigm for pharmacological interventions. Combinatorial therapies could be found by searching within biomimetic pharmacological sets with the same many-to-many structure as the biological systems and parameters within the ranges we observed in biology. The molecular tools for testing this new approach have recently become available. The necessary experiments would be greatly accelerated by a concerted effort of several pharmaceutical and biotech companies willing to pool compounds. This effort has potential benefits for the therapies of complex diseases, for the pharmaceutical industry and for our basic understanding of biological control.
Submission history
From: Giovanni Paternostro [view email][v1] Thu, 3 Jun 2010 19:56:45 UTC (796 KB)
[v2] Tue, 21 Dec 2010 23:01:57 UTC (886 KB)
References & Citations
Bibliographic and Citation Tools
Bibliographic Explorer (What is the Explorer?)
Litmaps (What is Litmaps?)
scite Smart Citations (What are Smart Citations?)
Code, Data and Media Associated with this Article
CatalyzeX Code Finder for Papers (What is CatalyzeX?)
DagsHub (What is DagsHub?)
Gotit.pub (What is GotitPub?)
Papers with Code (What is Papers with Code?)
ScienceCast (What is ScienceCast?)
Demos
Recommenders and Search Tools
Influence Flower (What are Influence Flowers?)
Connected Papers (What is Connected Papers?)
CORE Recommender (What is CORE?)
arXivLabs: experimental projects with community collaborators
arXivLabs is a framework that allows collaborators to develop and share new arXiv features directly on our website.
Both individuals and organizations that work with arXivLabs have embraced and accepted our values of openness, community, excellence, and user data privacy. arXiv is committed to these values and only works with partners that adhere to them.
Have an idea for a project that will add value for arXiv's community? Learn more about arXivLabs.